Screener
ADMA Biologics ADMA Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's inventories?
- ADMA Biologics (ADMA) reported inventories of $239.31M in Q2 2026.
- How has ADMA Biologics's inventories changed year-over-year?
- ADMA Biologics's inventories increased by 25.0% year-over-year, from $191.46M to $239.31M.
- What is the long-term trend for ADMA Biologics's inventories?
- Over 5 years (2020 to 2025), ADMA Biologics's inventories has grown at a 20.4% compound annual growth rate (CAGR), from $81.54M to $206.47M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about ADMA Biologics's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude